The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

FluMist Home, like the original version administered in medical offices and pharmacies, is for adults under age 50 and kids 2 ...

The at-home use of the FluMist naval spray vaccine is on its way. The FDA approved AstraZeneca’s spray to be used outside of ...

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can administer it themselves.

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).